e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Idiopathic pulmonary fibrosis and rarities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting survival in interstitial lung disease (ILD): Multidisciplinary team (MDT) diagnosis versus technetium-99m diethylene triamine pentacetic acid (DTPA) clearance scans
A. Dwarakanath, S. S. Win, M. Elliiott, M. Darby, P. Beirne (Leeds, United Kingdom)
Source:
Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Session:
Idiopathic pulmonary fibrosis and rarities
Session type:
Poster Discussion
Number:
467
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Dwarakanath, S. S. Win, M. Elliiott, M. Darby, P. Beirne (Leeds, United Kingdom). Predicting survival in interstitial lung disease (ILD): Multidisciplinary team (MDT) diagnosis versus technetium-99m diethylene triamine pentacetic acid (DTPA) clearance scans. Eur Respir J 2013; 42: Suppl. 57, 467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Prognostic value of dual-time-point
18
F-FDG PET in fibrotic idiopathic interstitial pneumonia
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Relationship between HRCT findings and clearance of technetium -99m-DTPA in the evaluation of patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: Eur Respir J 2002; 20: Suppl. 38, 457s
Year: 2002
18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
The 18F PET/CT scan in patients with chronic sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
The utility of 18F-FDG PET/CT in chronic sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Interstitial lung disease (ILD) in juvenile systemic sclerosis (JSS): correlation between high-resolution computed tomography (HRCT) and pulmonary function test (PFT) changes
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008
Multi-detector row computed tomography in imaging of interstitial lung diseases
Source: Annual Congress 2013 –Functional imaging
Year: 2013
Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD)
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
High resolution computed tomography (HRCT) can differentiate rapid from slow progressing Idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014
Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: an F-MISO PET/CT study
Source: Eur Respir J, 58 (4) 2004584; 10.1183/13993003.04584-2020
Year: 2021
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Longitudinal high-resolution computed tomography (HRCT) assessment and disease progression in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic therapy
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Synoptical table of idiopathic interstital pneumonia (IIP) findings in computed tomography (CT) – A practical tool and systematic review
Source: International Congress 2014 – ILDs 5
Year: 2014
High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017
Solitary pulmonary nodule evaluation with 99mTc-methoxy isobutyl isonitrile in a tuberculosis-endemic area
Source: Eur Respir J 2007; 30: 1090-1095
Year: 2007
Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Prevalence of interstitial lung disease (ILD) in a lung cancer screening program using low-dose computer tomography (CT)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011
3D-simulation in an integrated assessment of the dynamics in patients with disseminated pulmonary lesions (DPL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept